Chamber Weighs In on HHS Vaccine Policy Overhaul

The U.S. Chamber of Commerce has formally responded to a Department of Health and Human Services request for information on how federal vaccine recommendations are categorized and how shared clinical decision-making should function in American health care.

The letter, dated September 18, 2026, is addressed to Cynthia Goss, Deputy Assistant Secretary for Planning and Evaluation, Health Policy at HHS, at the department's Washington headquarters at 200 Independence Avenue, S.W. The submission responds to Docket No. HHS-OS-2026-0332, published in the Federal Register at 91 Fed. Reg. 54,724 on August 24, 2026.

The stakes for employers are direct. The Chamber describes itself as the world's largest business federation, representing businesses of all sizes, sectors, and regions. Its membership includes employers that provide health coverage to millions of American workers and their families. Any change to how federal vaccine recommendations are framed therefore flows through employer-sponsored insurance, benefit design, and workplace health programs.

In its opening statements, the Chamber aligns itself with the Administration's objectives on vaccine policy. "The Chamber shares the Administration's goal of ensuring Americans have access to safe, effective," the letter states, before its public excerpt cuts off. The organization frames its position as supportive of access to vaccines while engaging on the structural questions HHS has raised.

At issue is the categorical framework the federal government uses when it issues vaccine recommendations, and the role of what HHS calls shared clinical decision-making — an approach that shifts certain vaccination choices away from blanket, category-based guidance and toward case-by-case deliberation between patients and clinicians. HHS opened the docket in August to gather input on how these categories operate and whether the shared decision-making model should play a larger role.

For the employer community the Chamber represents, the outcome matters on several fronts. Vaccine recommendation categories influence insurance coverage requirements, preventive care benchmarks, and the practical decisions benefits administrators make for large insured populations. A move toward individualized clinical decision-making could complicate standardized benefit design, while changes to recommendation categories could affect which vaccines and services employer plans must cover.

The full text of the Chamber's submission is available through its health care policy page, and the underlying docket remains part of the public HHS rulemaking record.

The comment period response signals that employer groups intend to be active participants as HHS weighs structural changes to federal vaccine policy — a process that could reshape preventive care standards across employer-sponsored health plans covering millions of Americans.